NLRP3 and Sepsis: It activates inflammasomes, such as absent in melanoma 2 (AIM2) and NLRP3, to promote the release of IL-1β and IL-18, enhance pathogen clearance, and modulate inflammation, particularly in sepsis and endotoxemia (12, 38, 88).